BioMerieux SA recalls ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a quantitative technique for determining the an…
- Recall date
- April 25, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2095-2017
- FDA classification
- Class II
- Brand / firm
- BioMerieux SA
- Sold / distributed
- NATIONWIDE DISTRIBUTION TO AL, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, IL, IN, IA, KS, KY, LA, M, MA, MD, MI, MN, MS, MO, MT, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, and WY
Why it was recalled
False susceptible results
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria (Only 531640 was distributed in the United States)
Get recall alerts
Free email alert whenever BioMerieux SA has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: BioMerieux SA